Literature DB >> 825900

Effects of thymoleptics on behavior associated with changes in brain dopamine. II. Modification and potentiation of apomorphine-induced stimulation of mice.

L Molander, A Randrup.   

Abstract

The thymoleptics potentiate and modify the behavioral effects of apomorphine (probably the most specific dopaminergic agonist) as well as those of Dopa. The effect of the thymoleptics is not abolished by emptying of amine stores, and this together with other evidence suggests that these drugs facilitate the access of apomorphine to the dopamine receptors. The effects of thymoleptics on elements of animal behavior that can be associated with brain dopamine appear interesting on the background of a considerable body of evidence indicating an association of brain dopamine with depression and mania (references).

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 825900     DOI： 10.1007/BF00427282

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


  24 in total

1.  Noradrenergic influence on the stereotyped behaviour induced by amphetamine, phenethylamine and apomorphine.

Authors:  E Mogilnicka; C Braestrup
Journal:  J Pharm Pharmacol       Date:  1976-03       Impact factor: 3.765

2.  Differences between the effects of acute and long-term treatment with desmethylimipramine on reserpine-induced release of amines from rat brain.

Authors:  S Roffler-Tarlov
Journal:  Biochem Pharmacol       Date:  1975-07-15       Impact factor: 5.858

3.  [Apomorphine synergism (inducedgnawing in mice) as a test for the differentiation of psychotropic substances].

Authors:  L THER; H SCHRAMM
Journal:  Arch Int Pharmacodyn Ther       Date:  1962-07-01

4.  [Biochemical findings in the brain in endogenous depression].

Authors:  V E Neumayer; P Riederer; W Danielczyk; D Seemann
Journal:  Wien Med Wochenschr       Date:  1975-05-23

5.  Comparative studies of a new 5HT-uptake inhibitor and some tricyclic thymoleptics.

Authors:  J B Lassen; E Petersen; B Kjellberg; S O Olsson
Journal:  Eur J Pharmacol       Date:  1975-05       Impact factor: 4.432

6.  Effects of thymoleptics on behaviour associated with changes in brain dopamine. I. Potentiation of dopa-induced gnawing of mice.

Authors:  L Molander; A Randrup
Journal:  Psychopharmacologia       Date:  1976-02-02

7.  Potentiation by desipramine of the pressor and depressor effects of dopamine.

Authors:  K Kadzielawa; M Popielarski
Journal:  J Pharm Pharmacol       Date:  1971-07       Impact factor: 3.765

8.  Enhancement of methylphenidate-induced stereotypies by repeated administration of neuroleptis.

Authors:  B Fjalland; I Moller Nielsen
Journal:  Psychopharmacologia       Date:  1974-01-11

9.  The effect of tricyclic antidepressants on apomorphine-induced hypothermia in the mouse.

Authors:  J Maj; L Pawlowski; G Wiszniowska
Journal:  Pol J Pharmacol Pharm       Date:  1974 May-Jun

10.  Role of catecholaminesi in compulsive gnawing behaviour in mice.

Authors:  V Pedersen
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739
View more
  8 in total

1.  Dopamine autoreceptors in the ventral tegmental area show subsensitivity following withdrawal from chronic antidepressant drug treatment.

Authors:  A Towell; P Willner; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Single treatments with the antidepressant oxaprotiline and its (+) and (-) enantiomers increase behavioural responses to dopaminergic stimulation in the rat.

Authors:  A Delini-Stula; E Mogilnicka
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

3.  Behavioral effects of apomorphine and diisobutyrylapomorphine in the mouse.

Authors:  R J Baldessarini; N S Kula; K G Walton
Journal:  Psychopharmacology (Berl)       Date:  1977-06-06       Impact factor: 4.530

4.  Changes in drug-induced stereotyped behavior after 6-OHDA lesions in noradrenaline neurons.

Authors:  C Braestrup
Journal:  Psychopharmacology (Berl)       Date:  1977-01-31       Impact factor: 4.530

Review 5.  The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence.

Authors:  Gabriele Sani; Giulia Serra; Giorgio D Kotzalidis; Silvia Romano; Stefano M Tamorri; Giovanni Manfredi; Matteo Caloro; C Ludovica Telesforo; Saverio S Caltagirone; Isabella Panaccione; Alessio Simonetti; Francesca Demontis; Gino Serra; Paolo Girardi
Journal:  CNS Drugs       Date:  2012-08-01       Impact factor: 5.749

6.  Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice.

Authors:  M Vasse; P Protais; J Costentin; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

7.  Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression.

Authors:  A Randrup; C Braestrup
Journal:  Psychopharmacology (Berl)       Date:  1977-08-16       Impact factor: 4.530

8.  Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide.

Authors:  R M Post; D C Jimerson; W E Bunney; F K Goodwin
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.